To assess the stability of different measures of receptor occupancy from [llC]raelopride (a D2 antago nist) studies with positron emission tomography, we an alyze data from five testlretest studies in normal volun teers in terms of individual model parameters from a three-compartment model, the distribution volume (DV) and the ratio of DVs from a receptor-containing region of interest to a non-receptor-containing region. Large vari ations were found in the individual model parameters, limiting their usefulness as an indicator of change in re ceptor systems. The DV ratio showed the smallest vari ation. Individual differences were reflected' in the greater intersubject variation in DV than intrasubject variation. The potential effects of blood flow on these measure ments were addressed both experimentally and by simu lation studies using three models that explicitly incorpo rate blood flow into a compartmental model that also in-
The distribution volume (DV) has been used ex tensively to monitor changes in receptor systems probed with reversibly binding radiotracers such as e1C]raclopride (Dewey et aI., 1992 (Dewey et aI., , 1993 Volkow et aI., 1994) , [JlC] cocaine (Logan et aI., 1990) , [llC] flumazenil (Holthoff et aI., 1991) and e8p]cy clofoxy (Carson et aI., 1993) . The DV is defined as eludes receptor-ligand binding. None of the models showed any variation in the DV with changes in blood flow as long as flow was held constant during the simu lation. Experimentally, blood flow was significantly re duced by hyperventilation in a human subject. The DV was found to be reduced relative to baseline in the hyper ventilation study, but the DV ratio remained unchanged. The effect of elevated and reduced flow was also tested in two baboon experiments in which Pe02 was varied. Some variability in the DV ratio was observed but was not cor related with changes in blood flow. This raises the possi bility that other factors indirectly related to changes in blood flow (or Pe02) may cause changes in DV, and these effects need to be considered when evaluating experimen tal results. Key Words: Raelopride-Positron emission to mography-Blood flow-Compartmental models-D2 re ceptors.
the ratio of tissue drug concentration to plasma drug concentration under conditions when plasma and tissue concentrations are constant. Since the plasma drug concentration is not usually held con stant [generally the drug is administered as a bolus injection, although recently Carson et al. (1993) have proposed an infusion protocol for e8p]cyclo foxy to maintain a constant plasma level], the tis sue/plasma drug ratio does not represent the true DV but also contains factors representing the loss of drug from plasma (Logan et aI., 1990 ; Carson et aI., 1993) . Por this reason, when using a bolus in jection of tracer, the DV must be determined using compartmental modeling (finding values for individ ual kinetic parameters for a specified model) or graphically (not assuming a specified model) (Logan et aI., 1990) . The DV as used by Holthoff et al.
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(1991) and Koeppe et ai. (1991) is determined from a two-compartment two-parameter model that does not explicitly contain receptor parameters. Used in this way, the two-compartment model is equivalent to the (model-independent) graphical method. The utility of the DV is that it is a linear function of the free receptor concentration (which is a useful mea sure provided that it is not dominated by nonspe cific binding in which case changes in free receptor concentration may not be seen). The advantages of the DV are that it is easily determined graphically (Logan et aI., 1990) , it should be insensitive to changes in blood flow [Holthoff et ai. (1991) have shown that the DV for e lC]flumazenil was un changed after visual stimulation that altered blood flow regionally], and it should be a more stable mea sure of change in a receptor system than individual model parameters determined from compartmental analysis (Carson et aI., 1993) . In addition to being a fu nction of free receptor concentration, the DV is proportional to the ratio of transport constants (plasma to tissue/tissue to plasma) that are also fu nctions of plasma protein binding and tissue non specific binding. By taking the DV ratio of a recep tor-containing region [such as the basal ganglia (BG) containing the D2 receptor] to that of a non receptor-containing region [cerebellum (CB)], the dependence on plasma protein binding contained in the transport constants is eliminated, leaving a lin ear function of receptor occupancy that can also serve as a probe of changes in neurotransmitter concentration.
By altering the number of available receptors, en dogenous dopamine (DA) affects the binding of ra diotracers for the DA D2 receptor (Seeman et aI., 1989; Dewey et aI.,1991; Logan et aI., 1991; Ross, 1991; Young et aI., 1991) . We have used positron emission tomography (PET) and [llC] raclopride, a D2 receptor antagonist with a similar affinity for the DA D2 receptor as DA itself, to examine changes in synaptic DA concentration after pharmacological intervention (Dewey et aI., 1992 (Dewey et aI., , 1993 Volkow et aI., 1993a,b) . Since the drugs used to induce these changes in synaptic DA levels can have other phys iological effects such as to alter blood flow, it is important to determine the response of e lC]raclo pride binding to changes in blood flow and to inves tigate possible effects of flow on the DV when the DV is determined by bolus injection. A complicat ing factor brought out in recent work by Uier et al. (1993) is that transient reductions in cerebral blood flow secondary to bilateral occlusion of carotid ar teries lead to an increase in extracellular DA as measured by microdialysis in rats. However, the secondary effects of transient carotid occlusion to J Cereb Blood Flow Metab, Vol. 14, No.6, 1994 achieve lower blood flow may not be the same as those of Pc02 or drugs.
We report here the use of model simulations to predict how differences in blood flow alone (assum ing no accompanying change in DA levels) could affect measures used to assess e lC]raclopride bind ing. Blood flow values from 0.2 to 0.8 ml g � 1 min � 1 were investigated by simulation. In some simula tions the blood flow values were held constant for the duration of the simulation, while in others the flow values varied during the simulation. The per meabilities used for the simulations were similar to those found for raclopride and (for comparison) for cocaine, which has a greater plasma-to-tissue per meability than raclopride. Three models differing in their description of the capillary tracer concentra tion were used in the simulations. Results were as sessed in terms of the transport constant K l and the DV. Changes in blood flow were induced experi mentally in a human subject by hyperventilation (decreased flow) and by controlling Pco2 to give high and low blood flow in two studies in anesthe sized baboons. That hyperventilation induces a de crease in cerebral blood flow was demonstrated by Kety and Schmidt (1945) , and recently PET studies with H21 5 0 have shown a global reduction in flow induced by hyperventilation (Bednarczyk et aI., 1990) . Results from the human hyperventilation ex periment that we report are compared with results from serial raclopride studies in five human subjects under resting conditions (test/retest protocol). In light of the potentially complicating factor of DA release (Uier et aI., 1993) , further experimental studies manipulating blood flow were not carried out and the focus is instead on model predictions of blood flow changes. A second purpose of this work is to compare the five test/retest studies with re spect to the reproducibility of the individual model parameters describing the transport and binding of [llC]raclopride in the BG and CB determined from compartmental analysis to the reproducibility of the DV and the DV ratio for BG/CB, which are related to the free receptor concentration. The goal was to determine the most stable parameter to use in as sessing [llC]raclopride binding. Values for the DV for the five test/retest studies have been previously reported by Volkow et ai. (1993a) .
THEORY
In this section we relate the DV to model param eters for the standard two-and three-compartment models fr equently applied to the analysis of PET data. The relationship between the transport param eters of the two-and three-compartment models and blood flow is made through the use of more complex models that explicitly include blood flow. Simulated data were generated using models incor porating blood flow and analyzed using the DV and the standard compartmental models (Eqs. 1 and 2) to determine the apparent effects on model param eters due to changes in blood flow. (See Appendix A for definitions of terms used in the following der ivations.) Model equations for the three compartment model commonly used to describe the binding of radiotracer to receptor are given by (1) where Ca(t) is the arterial plasma concentration of radiotracer, K J is the plasma-to-tissue transport constant, (an implicit function of blood flow, per meability, and plasma protein binding), k2 (a func tion of blood flow, permeability, and tissue nonspe cific binding) is the tissue-to-plasma efflux con stant, C3 is the concentration of radiotracer bound to receptors, and C2 is the non-receptor-bound con centration. Model parameter k3 is proportional to the free receptor concentration (Bmax -L), where L is the concentration of endogenous neurotrans mitter bound to receptor, and k4 is the receptor dis sociation constant [kik4 ex (Bmax -L)/Kd]. Negli gible receptor occupancy by the injected radioli gand is assumed so that free receptor concentration does not change during the experiment.
For a two-compartment model (no receptor bind ing),
Equations 1 and 2 can be analyzed graphically (Lo gan et aI., 1990) to give the DV, which is (for a two-compartment model applied to a region without D2 receptors such as the CB)
NS represents the ratio of kinetic constants for non specific binding, which is assumed to be sufficiently rapid that it is always in a steady state (Mintun et aI., 1984) . With this definition k2 = k;/(1 + NS), where 11(1 + NS) = iN S is the free fraction of tracer in tissue. For a three-compartment model (for ex-ample, the BG, a region containing DA D2 recep tors), the DV is given by
The free receptor concentration IS related to the ratio of the DV s:
assuming the ratio K/k' 2 is the same for both re gions. We have defined (Bmax -L) = Bmax' and Kd = Kd' /(1 + NS).
To consider explicitly the effects of blood flow, it is necessary to have a model describing the ex change of material between tissue and capillary. Several models of capillary-tissue exchange have previously been developed for the purpose of un derstanding and interpreting data from indicator di lution experiments. These models differ in their as sumptions and complexity. All are based on a single capillary model. Bassingthwaighte (1974) consid ered movement of material within the capillary in terms of axial diffusion as well as bulk flow, extra vascular axial diffusion, and permeability gradients of the capillary. Lateral diffusion was assumed to be infinitely rapid, characteristic of a well perfused organ, a simplifying assumption from an earlier model (Bassingthwaighte et aI. , 1970) . Goresky et al. (1970) considered a model in which transport along the capillary occurs only as a result of bulk flow (convection) with rapid diffusion in the axial direction (perpendicular to the capillary). In this model concentration gradients along the length of the capillary are allowed for material both in the capillary and in the extravascular space. The model of Johnson and Wilson (1966) applies the further assumption that the extravascular space is homoge neous with respect to spatial distribution. Sawada et al. (1989) conclude, on the basis of work by Yoshida and Skuta (1984) , that the capillary net work of the brain as viewed by scanning electron microscopy is consistent with the homogeneous tis sue model. Sawada et al. extended the model of Johnson and Wilson to allow different permeabili ties for plasma-to-tissue and tissue-to-plasma trans fer and applied this model in an analysis of eH]cy clofoxy in the rat brain (Sawada et aI., 1991) . One of the models (Model I) used in this study is the same as that of Sawada et al. (1991) with a different method of solution. The derivation of equations from this model can be found in Appendix B, with the result that the average capillary concentration is given by
In the steady state (which assumes a constant tissue concentration over the time of capillary tran sit), Cc bcomes (7) The coefficients <Xi and [3i are given in Appendix A and are functions of blood flow and the permeabil ity-surface area products PS I (plasma to tissue) and PS2 (tissue to plasma) but also contain a term for nonspecific binding (see Appendix A). With use of the average capillary concentration Cc from Eq. 6, the time rate of change of tissue (not receptor bound) concentration for a two-compartment mod el is (8) and for a three-compartmental model Equation 6 differs from Eq. 7 in the terms <X I ' <X2' [31' and [32' which can be shown to be proportional to powers of V B/ P S), where VB is the tissue blood vol ume (see Appendix A). Substituting Eq. 6 into Eq. 8 (or Eq. 9 for a three-compartment model) gives (Model I) (derivation given in Appendix C) [Sawada et al. (1991) gives the conventional definitions K1 = F(1e -P SII F) , k2 = (PS2/PS I )F(1 _e-P S / F) , with K)/k2 = PS I /PS2 = PS'/p/(PS lfN S ) ' A third model (Model III) used for the incorpo ration of blood flow is that of Mintun et al . (1984) . Model equations for a two-compartment model are as follows:
where C) is the capillary concentration and other terms have the same meaning as in the previous models. This model assumes a uniform capillary concentration (referred to as the "venous equilib rium model"). Equations for the three-compart ment versions of Models I, II, and III are given in Appendix C.
METHODS

PET studies and data analysis
With use of tracer doses of [lIC]raclopride (specific activity 0.5-l .5 CiI/LM), duplicate PET studies were per formed on each of six normal subjects. For five of the subjects (nos. 1-5), a test/retest protocol was followed using the same conditions for both studies with the sec ond study carried out 24 h after the baseline. In one sub ject (no. 6), hypocapnia was induced by hyperventilation immediately prior to the second (retest) study, which was 2 h after the baseline study. Hyperventilation was started 10 min prior to injection of [llC]raclopride and was con tinued for a total of 40 min. The initial Pe02 of 38 mm Hg decreased with hyperventilation to 20 mm Hg prior to [11C]raclopride injection, to 22 mm Hg 20 min postinjec tion, and to 28 mm Hg at 30 min. Scanning was carried out for 60 min following injection of tracer. For details of the PET scanning procedures used, see Volkow et al. (l993a) .
For the baboon experiments, the animals were pre pared and anesthesized as described previously (Dewey et al. , 1992, and refs therein) . In the first experiment (7 A), Pe02 was maintained at 52-58 mm Hg (avg. 56 mm Hg) representing high blood flow ; in the second experiment (7B) , Pe02 was 25-33 mm Hg (avg. 29 mm Hg) , lowest blood flow ; and in the third experiment (7C), Pe02 was 36--43 mm Hg (avg. 41 mm Hg). Care was taken to ensure that the same level of anesthesia was maintained in all three studies and that blood pressure did not change. The injections were 2 h apart. A second set of studies was done with Pe02 at 53 and 40 mm Hg (experiments 8A and 8B, respectively).
Data from the PET studies with [IIC]raclopride were analyzed using both a nonlinear least-squares (NLSQ) fit to Eqs. 1 and 2 for regions of interest (ROIs) from the BG and the CB and the graphical analysis. For the least squares fit, the model equations were solved numerically (Shampine and Gordon, 1975) , assuming equal weights for each point. For BG the equations were integrated to 60 min. For CB the equations were integrated to 42 min due to lower counts in this region. The model equations were integrated over the time of the scan. Optimum val ues were found by a simplex search method (Press et aI ., 1986) , minimizing the sum of the squared differences be tween the measured PET value and the model prediction.
An approximated blood volume correction (4.0%) was subtracted from the PET data prior to parameter optimi zation. Radioactivity from the arterial plasma measure ments (corrected for the presence of the labeled metabo lites of elClraclopride) formed the input function to the model equations. At any time point, the value of the input function was determined by a linear interpolation be tween two values of the total measured radioactivity mul tiplied by the fraction of that radioactivity representing unchanged raclopride. To estimate values for the model parameters k3 and k4' the ratio K II k2 was fixed at the value for the cerebellum. This assumes thatfNs (nonspe cific binding) is nearly the same in both structures and that the ratio of permeabilities (PS IIPS2) is the same.
Experimental details and results from the graphical analysis are given by Volkow et al . (1993a) . Results from the graphical analysis presented here differ somewhat from the earlier results due to subtraction of an estimated blood volume (4 .0%) contribution from the PET data prior to analysis and averaging values of the slope found for times between 12 min and each of the last three time points (47-60 min) for BG and 12-42 min for CB. Results from the graphical analysis are compared to model pa rameters determined from the NLSQ model fit (Table I) .
Re sults from the hyperventilation study are given in Ta ble 2 and model fits are shown in Fig . I (left) .
The testlretest (intrasubject) variability is expressed as a percentage change of the parameters between the two studies (Tables IC and ID) and also as a (percentage) coefficient of variation (COV) (COV = SD/mean x 100) calculated from the average of the COVs for each subject. Although only two measurements were made on each in dividual subject (more studies were not possible because of radioactivity exposure limits), the calculation of a COY for each of the five subjects allows a comparison of the intrasubject and intersubject variability calculated from the average values for each subject.
Simulations
With use of the three models of blood flow described in the previous section, the effect of changes in blood flow on model parameters and on the DV was determined by generating data using experimental input functions from human studies with ["C]raclopride and for comparison [llC] cocaine . For the constant (over the time of the sim ulation) flow studies, only Models I and III could possibly show a deviation in the DV with changing flow since dif ferences in blood flow cannot affect the DV of Model II (the ratio K/k2 is independent of flow). The two sets of model parameters used in the simulation studies are given in Tables 4A and 4B . Results reported in Table 4A were based on data generated with parameters similar to those found for raclopride , that is, PSI = 0.13 , which repre sents a low permeability . A higher permeability was used in the cocaine simulation (PSI = 0.45) consistent with what was found in human studies (Logan et aI. , 1990) . Flow values ranged from 0.2 to 0.8 ml g-I min -I. Flow values that varied linearly over the course of the simula tion were also used; results are given in Table 5 . Changes in flow due to hyperventilation have been shown to be due to vasoconstriction (Raichle et aI ., 1970) , which re duces the blood volume VB as well as flow F but also reduces the permeability surface area (PS I ) ' For purposes of these calculations, we have varied only F, maintaining the other parameters at a constant value.
The simulated data generated using Eqs. 10 , 12, 13 , C6', C7 , and C8, were analyzed using the graphical tech nique and an NLSQ fit to the model equations given by Eqs. 1 and 2, which are frequently used in the analysis of PET data and do not require a knowledge of blood flow. When the receptor parameters k3 and k4 were determined in the least-squares fit, the ratio K/k2 was fixed at the value found for the CB (two-compartment model).
RESULTS
Experimental results
Test/retest. A descriptive analysis of time radioactivity data for tissue uptake and plasma clearance has been reported previously (Volkow et aI. , 1993a) along with a quantitative analysis in terms of the OV and the OV ratio of BG to CB. Time to peak uptake was found to range from 9.5 to 22.5 min. The average time from injection to peak radioactivity in plasma (test/retest) was =34 s with differences of 5-10 s between studies commonly seen. Tables lA and IB contain values for model parameters and OVs for CB and BG ROls as well as the OV BG/CB ratio. Bmax' /Kd' is given by kik4 in the compartmental analysis and by Eq. 5 in the graphical analysis. Similar results in terms of test/ retest reproducibility were obtained using both methods. Table 10 gives the percentage variation in the model parameters for test/retest. The receptor parameters k3 and k4 show the greatest variation (> 100% in study 5). The intrasubject COVs are 20% (k3) and 18% (k4). Variation in the DV is less (Table  1C) , the largest change between studies being = 15% for both BG and CB with an intrasubject COY on the order of 5%. From Table 1C the DV BG/CB ratio and Bmax' / Kd' show less variation be tween studies than the individual DVs for BG. The ratio of DVs can compensate somewhat for errors in the input function and metabolite measurements since such errors would affect both regions. The largest BG/CB change between studies is -8% for study 1. For Bmax'/Kd' the intrasubject COY is 3%. The intersubject COY s for the DV and Bmax' / Kd' are =15%, considerably larger than the intrasubject COVs, indicating differences between individuals and the importance of using a subject as his/her own control. For other model parameters, variability in test/retest was sufficiently large that both inter-and intrasubject COVs were approximately the same.
Hyperventilation study. Peo2 at the beginning of the hyperventilation experiment indicates a sub stantial reduction in blood flow (cf. Bednarczyk et aI., 1990) from the baseline value. Although some recovery was observed by 30 min, Peo2 was still considerably less than baseline. Time-radioactivity curves for tissue uptake in BG and CB from the control study and the study in which blood flow was altered by hyperventilation are given in Fig. 1A . A lower uptake was observed for both CB and BG in the hyperventilation study. Plasma radioactivi ties are shown in Fig. lB . The plasma radioactiv ity in the hyperventilation study peaked between 15 and 20 s after injection compared with the con trol study, which peaked between 40 and 45 s. Plasma integrals differed by 3% at 30 min. Table 2 contains results from the kinetic analysis of data J Cereb Blood Flow Metab, Vol. 14, No.6. 1994 from this study. Decreases on the order of 20% oc cur in the DV for both CB and BG; however, only a small variation (2%) occurs in BG/CB (3% in Bmax' /Kd'). The largest variation in the model pa rameters occurs in K,. The smaller values of K, are responsible for the lower tissue uptake for both BG and CB in the hyperventilation than the control study.
Baboon Peo2 studies. Data from the baboon stud ies are given in Tables 3A and B and time radioactivity curves for study 7 are shown in Fig. 2 . In both studies, the higher Peo2 experiments re sulted in higher DV s for the CB (= 10% difference for Peo2 reduction from >50 to 40 mm Hg). In study 7 there was essentially no variation in the BG DV, while in study 8 the BG DV was found to be 20% lower in experiment 8B (lower Peo2). As a result, the variation in DV ratio is greater (average de crease of 10%) than in the human study with a larger change in Bmax' / Kd'. ["C]Raciopride integrated plasma radioactivities at 30 min for study 8 were 0. 20 x 10 5 (8A) and 0. 21 x 10 5 (8B) nCi min/cc, representing a small difference (5%). The plasma integrals for studies 7 A, B, and C were 0. 24 x 10 5 , 0. 27 X 10 5 , and 0.24 x 10 5 , respectively, with no difference between 7 A and C but an 11 % increase in B. From the test/retest studies reported by Dewey et al. (1992) , the average BG/CB ratio of DVs was 3. 0 (less than in human subjects, which averaged 4. 5) with 8% COY (intersubject) and 4% COY (in trasubject). The fraction of radioactivity in plasma due to ["C]raciopride was considerably less in the baboon than in the human subjects (30% at 30 min in the baboon compared with 70% at 60 min in hu mans). There were only small differences between experiments with varying Peo2. 
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For abbreviations see the text.
Simulations
Tables 4A, 4B and 5 contain results from the sim ulation studies using the three blood flow models. Simulation data for Table 4A were generated with a measured plasma input function (for [ I I C]racIo pride) using parameters similar to those found for [lIC]racIopride in humans, while data analyzed in Table 4B were generated with a measured plasma input function for e IC]cocaine using parameters similar to those of e I C]cocaine (Logan et al., 1990) .
There was no variation in the DVs from Tables 4A and 4B for either the two-or the three-compartment models with variations in flow ranging from 0.2 to 0.8 ml g -I min -I for any of the three models. There was some variation in K I of =20% between flows of 0.2 and 0. 8 ml g -I min -I for Models I and II with a greater variation for Model III (30%) ' (Table 4A ). There was also no variation in Bmax'lKd' from the expected value of 3 (k3Ik4) (simulations using [ I lC] _ raclopride parameters and input function). From Table 4B (cocaine parameters) the K I increased by approximately a factor of 2 when flow was in creased from 0.2 to 0.8 ml g-I min-I . Bmax'IKd' was also constant (0.88). Results from the variable flow calculation given in Table 5 indicate that small differences in DV can occur when flow is varied over the time course of the (simulated) experiment. The largest difference was a variation of 8% from the baseline value of DV for flows initially at 0.2 ml For abbreviations see the text. T,me (min) 0,07 g-I min -I and ending at 0.8 ml g-I min -I using cocaine parameters. Results for racIopride with variable flow are not given because the changes in the DVs were <1%. The average capillary concentrations for the three models are illustrated in Fig. 3 for the first 2 min after the bolus input. Differences in tissue up take for the different models are illustrated in Fig. 4 for the initial 10 min using measured input functions for raclopride and cocaine. There were no visible differences between Model I with or without the second-order correction terms, indicating that the first-order correction was sufficient.
DISCUSSION
An important consideration in the analysis of PET data is the separation of ligand-receptor bind ing effects from tracer delivery-flow effects. This is necessary to reliably assess changes in free receptor availability that occur as a result of a drug interven tion protocol that may also induce other physiolog ical changes. Considerations of delivery-flow ef fe cts on the determination of receptor parameters for irreversibly binding ligands have been presented by a number of authors (e.g., Wagner, 1986; Kim et aI., 1990; Logan et aI., 1991) . In the commonly used approach of fitting parameters to a compartmental model, the transport constants K] and k2' which are fu nctions of blood flow, capillary permeability, and plasma protein binding, are determined in addition to the receptor parameters k3 and k4. The parameter k3 should reflect possible changes in free receptor concentration, while k4 should not be affected. The large (intrasubject) variability of k3 (=20% ; Table  ID ) indicates that this parameter will not be of use Blood flow was varied from 0. 2 to 0. 8 ml g-I min-I. There was no difference between DV determined by graphical or com partmental analysis. Data were generated using PS I binding may partly explain the greater intrasubject variability in DV observed with raclopride com pared with the DV ratio, which does not depend upon f, . Other factors that affect the DV determi nation P are measurements of the input function and the metabolite correction to the input function. The effects of errors in these measurements are mini mized with the DV ratio.
The (intrasubject) variability observ�d in K I may be due to the physiological processes just men tioned (i.e., differences in plasma protein binding and blood flow between studies) as well as noise or errors in the input function measurement, while the variability observed in k3 and k4 is most likely due to noise since the values determined for k3 and k4 in the raclopride simulation cases (which were noise free) showed only small variations from the values used to generate the data. Farde et al . (1989) have also presented data on the kinetic analysis of e I C]_ raclopride in humans using PET. They found simi- F I refers to initial value of flow and F2 refers to flow at the end of the simulation. Flow was varied linearly over the time of the simulation (3 5 min). Data for raclopride are not given because no change in DV was seen with the variable flow simulation. .13, PS2 = 0.39, and F = 0.4 ml g -1 min -1. A two-exponential fit to the first 2 min of plasma data from a human raclopride study was used for the arterial input.
lar values for the model parameters (average values for BG in three subjects K I = 0.15, K l lk2 = 0.41, k3 = 0.51, k4 = 0.14) with k31k4 = 3.68, which is very close to the values reported here (Brnax'IKd/)' They could not, however, assess reproducibility since their second studies were at low specific activity. Reproducibility of raclopride binding as determined by the ratio of integrated radioactivities (from 21 to 33 min) for putamen to CB has been reported by Nordstrom et al. (1992) . The mean of the ratio of the integrated radioactivities of putamen to CB from study 2 (retest) to study 1 (test) was found to be 1.01 with an SD of 0.07, which is similar to the repro ducibility of DV ratios reported by Volkow et al. (1993a) and to Brnax'IKd' values reported here.
To probe more deeply into the potential effects of changes in blood flow on the model parameters and the DV, the simulation studies of Tables 4A, 4B, and 5 were carried out using three models with dif ferent values of blood flow. The data were analyzed in terms of the classic compartmental model of Eq. 1 (which does not explicitly include flow) and graphically for the DV. From Eqs. 12 and C7, KI and k2 of Model II are functions of flow and the permeability products, but the ratio K l lk2 (the DV for the two-compartment model) is independent of flow, although it is a function of plasma protein binding and tissue nonspecific binding . When F p PS I ' K I = PSI and k2 = PS2, so that for low per meabilities the transport constants themselves do not vary greatly with flow (PS 1 , however, may vary with flow due to a change in capillary surface area, but these effects are not considered here). In the raclopride simulations for which PS 1 was set to 0.13, KI varies =5% (Models I and II) for flows between 0.4 and 0.8 ml g-l min -I (at which KI is close to its PSI limit). Therefore, regional variations in K I (av erage values of 0.09 for CB and 0.14 for BG) are not expected to be due to differences in blood flow but to differences in PSI' for example, a difference in capillary surface area or permeability of the capil lary itself.
Model I is more general than the steady-state model (Model II), allowing for variations in tissue concentration over the time of capillary transit. The approximation is made that C2 (and Ca) do not change greatly over tc so that a Taylor series expan sion is sufficient to describe any variation from the initial value . From Tables 4A and 4B there is no variation in the DV with variations in flow when flow is constant for the duration of the simulation. From Eq. 10 for the two-compartment model, the ratio of the coefficient of Ca to the coefficient of C2 (K/k2) is unaffected by the correction term [1 -PSI(CXI + CX2'YO)) since it cancels in the ratio. There fore, the correction terms to C2 will not affect the DV. The only possible effects on the determination of the DV occur when the plasma concentration is changing rapidly, but as long as the contributions from the derivatives of Ca are small (which depend on the values of 131 and 132), the DV will be the same as for Model II. This is the case since at 0.6 min (close to the maximum in the plasma curve used), the ratios I3ldCaldtll3oCa(t) and 132d 2 Caldt 2 /13oCa are 0.14 and 0.02, respectively (for F = 0.4 ml g-I min-I and PS I = 0.13 mi g-I min-I , while at 1 min the ratios are 0.07 and 0.01, respectively). These ratios become larger for smaller flow, although this does not appear to affect the DV due to the short duration of their effect. Similarly for the three compartment model (neglecting the effects of I3ldCaldt and 132d 2 Caldt 2 ), the DV calculated for Eq. C6 is the same DV as is given by Eq. C7. Even though the DVs are the same for all three models, there are some differences between them in terms of predicted capillary concentration and tissue up take. Figure 3 compares capillary concentration over a 2-min period for blood flow values of 0.4 ml g-I min-I (for PSI = 0.13 and PS2 = 0.39) . The upper curve is Model I, the second curve (dashed line) is Model II, and the lower curve is Model III. Model I appears to be shifted slightly with respect to Model II due to the different signs of dCaldt be fore and after the peak radioactivity. For ease of calculating the second derivatives of Ca, an expo nential fit was used for the input function; however, since the second derivatives made a negligible con tribution, indistinguishable from that calculated with the first-order correction, the simulations re- Vol. 14, No.6, 1994 ported in Tables 4A, 4B , and 5 used actual plasma data with a linear interpolation between points. There are small differences in tissue concentra tion (Fig, 4) between Models I and II that become larger at smaller values of flow. The tissue concen trations illustrated do not contain a contribution from radioactivity due to blood within the capillar ies, which is always present in the experimental data. The blood volume contribution to total radio activity would be greater than the differences be tween the simulated curves. The differences be tween the models represent small perturbations that are compensated for by variations in K I that are <8% for F = 0.4. Smaller capillary concentration and therefore lower tissue uptake are observed for Model III, which accounts for the smaller KI deter- .45 and PS2 = 0.24) using a measured (human) cocaine input function with F = 0.4 ml g-1 min -1. Upper curve is for Model I, second curve is for Model II, and lower curve is for Model III. mined from curves generated with this model. The differences between all three models become small at large flows. Capillary concentration for PS I = 0.45 in general was significantly reduced due to the greater capillary permeability (results not shown). The magnitude of the effects is proportional to pow ers of V BI PSI and will be larger for smaller perme abilities.
Varying flow over the course of the simulation made a difference only in the case of cocaine due to the larger permeability, suggesting that variable flows could affect the DV for ligands with large per meabilities. This effect was evident in all models, even the steady-state Model II, which cannot be sensitive to flow values as long as flow is constant for the simulation. It is, however, unlikely that flow would vary to the extent considered here so this should not be much of a problem. Sawada et al. (1991) showed that the DV calcu lated for cyclofoxy was the same for both the clas sic compartmental and the physiological model con taining flow that is consistent with the results re ported here. This confirms that within the homogeneous tissue model (with convective flow), the DV is stable with respect to changes in blood flow. Since the homogeneous model should apply to brain tissue, as discussed by Sawada et al. (1989) , the variations in DV observed in Table lA and IB are most likely due to other mechanisms. The change in the DV in the nonreceptor region (CB) is due to a change in the ratio PSIIPS2 = Kl/k2• Since the same surface area occurs in both PSI and PS2, a change in blood volume (capillary recruitment) from one study to the next would not change the ratio. Also if the uptake process is one of diffusion across the blood-brain barrier, the permeability should be the same in both directions. One factor that could affect this ratio, however, is a change in the free fraction in plasma. Because raclopride is a tertiary amine that also contains a phenolic group, its microscopic acid-base behavior is complex (Tsai et aI., 1993) , opening the possibility that changes in plasma pH produced in the hyperventilation exper iment could change the ionization and molecular dynamics of the molecule. This in turn could change the free fraction in plasma and the partitioning be tween aqueous and organic phases (also the recep tor phase). Changes inJp due to the increase in pH resulting from hypocapnia may be part of the reason for the large decreases (=20%) in DV for CB and BG in the hyperventilation study and in baboon CB at lower Peoz levels. Since it was not possible to measure the free fraction while maintaining the Peo2 levels attained in the hyperventilation experi ment, the free fraction was measured in baboon plasma by altering pH (Peoz and pH are related through the Henderson-Hasselbalch equation). The preliminary results are as follows:fp = 0.16 ± 0.03 at pH = 7.4,fp = 0.13 ± 0.03 at pH = 7.1, andJp = 0.09 ± 0.002 at pH = 8.0 (n = 3). Although there is a possible trend toward a smaller free fraction at increased pH (decreased Peoz), there is consider able variability in these measurements and the re lationship does not appear to be linear. The associ ation between changes inJp and pH (Peo2) is clearly complex and will require a more detailed study. The variability in the measuredJp values is another rea son why the DV ratio is a more stable measure for comparing experiments with raclopride than the DV corrected for Jp (DVifp) ' Other drugs have been shown to be sensitive to changes in pH. Sawada et al. (1990) found that free quinuclidinyl-[1 2 5I]iodobenzilate was very sensitive to changes in pH in the range 6.0-7.0 due to an increased ionization in the presence of metabolic acidosis. They speculated that the increased ioniza tion of the free fraction would result in a decrease in the transport constant across the blood-brain bar rier.
Although we have found the DV ratio to be the most stable measure of free receptor concentration, there is some variability in the baboon experiments in which Peoz was manipulated to change blood flow. The reduction in the DV ratio (BG/CG) of 14% for study 8 is greater than the average test/retest reported by Dewey et al. (1992) in which the aver age (1%1) was 5% for six studies with values ranging from 0 to 13%. This reduction in DV ratio is con sistent with the DA surge observed by Liier et al. (1993) as a result of a transient decrease in blood flow. Lier et al. (1993) also found that DA levels varied between experiments and returned to normal before the return of normal flow by reperfusion. The transient nature of the DA surge may explain why a similar decrease was not seen in experiment 7. If the timing of the administration of tracer did not coincide with elevated DA levels, the effect was not seen. In any case the variation in BG/CB be tween study 7 A and 7C is 8%, which is within the test/retest variability of e l C]raclopride in the ba boon (Dewey et al., 1992) . The larger differences between C and B and A and B (10 and 16%, respec tively) suggest that study B may be responsible for the larger variability in BG/CB. This study is asso ciated with Peo2 levels considerably lower than val ues measured during baseline or drug studies. The average end-tidal CO2 from baseline studies in ba boons (not necessarily with [l 1 C]raclopride was found to be 45 ± 3 mm Hg (n = 13; end-tidal CO2 was found to be =5 mm Hg greater than Peo2). The fact that the DV ratio in the human study remained constant may be due to the difference in experimen tal conditions. Baboon studies are done with anes thesia. Also the Peo2 levels in the human study could not be controlled to the same extent that they were in the baboon studies. It appears that changes in Peo2 may induce effects other than simply chang ing blood flow. We are currently monitoring Peo2 in baboon studies to determine possible effects. There is, however, no correlation in DV ratio with changes in blood flow, which is the main concern of this work.
Changes in the DV ratio observed by Dewey et ai . (1992 Dewey et ai . ( , 1993 after pharmacological intervention are considerably greater than the changes observed here. Administration of 'Y-vinyl--y-aminobutyric acid ('Y-vinyl-GABA; a GAB A transaminase inhibitor) or lorazepam (a benzodiazepine agonist) resulted in an increase in the DV ratio averaging 23% presumably due to a decrease in endogenous DA. With loraze pam, increases in the CB DV were observed, but the increase in the BG DV was greater. No change in CB DV was observed with 'Y-vinyl-GABA. Al though it has been shown in rats that GABAergic agonists do not change blood flow in CB or BG (Edvisson et aI., 1980) , Mathew and Wilson (1991) have reported decreases in cerebral blood flow fol lowing benzodiazepine administration to humans. The observed increase in DV as a result of this drug intervention is counter to the effects predicted by a decrease in flow with an accompanying increase in DA (Uier et aI., 1993) .
CONCLUSIONS
We have found considerable variability in the model parameters determined from duplicate stud ies on the same individual using [ l JC]raclopride. This variability occurs in the transport constants K\ and k2 as well as in the receptor-related parameters k3 and k4. There is also considerable variability in the ratio K\/k2' the DV for the non-receptor containing region. The most stable measure is the DV ratio or the ratio k3/k4' both of which can be determined from the NLSQ solution of Eq. 1 or from the graphical analysis using Eq. 5 (Logan et aI., 1990) . The large variability in the individual val ues of k3 is most likely related to noise rather than to fluctuations in the amount of endogenous neuro transmitter since the DV ratio remains constant.
Although the DV represents an equilibrium quan tity and as such is independent of blood flow, its determination from a study using a bolus injection of tracer can theoretically be affe cted by blood J Cereb Blood Flow Metab. Vol. 14, No.6, 1994 flow. Simulations based on a theoretical model-in corporating the effects of blood flow using the non steady-state single-capillary well mixed tissue model indicate that changes in flow affe ct the trans port constants but not the DV unless large fluctua tions in flow occur during a study with a highly permeable tracer. In this case, all models tested showed some change in DV. For simulations in which blood flow was maintained constant through out, the same DVs as given by the steady-state model (Model II) were found for both Model I and Model III, the venous equilibrium model (Mintun et aI ., 1984) , although the latter generally gave lower values for K \ except in the case when P S \ was on the order of blood flow. In spite of this calculated stability of the DV with respect to differences in blood flow, it appears that there are a number of factors including changes in pH and in synaptic DA concentration that may be associated with changes in blood flow. These may vary according to the ex perimental strategy used to change blood flow (hy perventilation, transient blood vessel occlusion, and/or use of drugs with different pharmacological profiles) and may affe ct the experimentally deter mined DV, The impact of this potential superposi tion of neurochemical changes accompanying changes in flow may also be tracer specific and must be taken into account when interpreting ex perimental results.
APPENDIX A Definitions
A Cross-sectional area of capillary (cm 2 )
Bmax Total receptor concentration per cc tissue (pmol/cc) Ca Arterial plasma concentration of (unme tabolized) radiotracer (nCilcc)
Ce(x,t) Concentration of tracer in capillary at time t and distance x along capillary (nCi/cc) re Laplace transform of Ce Ce Average of Ce over the capillary transit time ; = l ite 5&' CedT C2 Tissue concentration of radiotracer not bound to receptor (free + nonspecifically bound) (nCilcc) C 3 Tissue concentration of radiotracer bound to receptor (nCilcc) DV Distribution volume (mUg) f = f,lA Flow through a single capillary (cm 3 /time) F = N f,lA Blood flow per g tissue (ml g-'min -I) K, Plasma-to-tissue transport constant used in the two-or three-compartment models when blood flow is not explicitly modeled; K I is a fu nction of blood flow and plasma protein binding, which is assumed to be rapid compared to capillary transit time (ml g-I min-I) 
Derivation of Eq 6
Tracer within the capillary is assumed to be transported by capillary blood flow (convection) with negligible radial or longitudinal diffusion. The concentration in the capil lary itself is a fu nction of distance and time. The concen tration at the arterial end is assumed to be the arterial plasma concentration. The equation of mass balance adapted fr om Sawada et al . (1989) is where C2 is the tissue concentration at time t and Cc is the capillary concentration at point x along the capillary . Let t' = xiI!.. be the time for an element of plasma to travel a distance x within the capillary (I!.. 
For the steady-state case, the solution of Eq. B2 is as fo llows (Patlak and Fenstermacher, 1975) :
P2C2
Ce(T,t) = Cae-PIT + T (1 -e-P,T)
In these equations, no distinction has been made be tween fr ee tracer in plasma and tracer in plasma bound to plasma proteins. It has been assumed that equilibrium between fr ee and bound is rapidly achieved on a time scale shorter than the capillary transit time. Under these conditions PI is given by (Essassi et aI., 1989) where PP is the ratio of kinetic constants for binding to plasma proteins analogous to NS for tissue nonspecific binding andf p represents the free fr action in plasma. P; is therefore the true permeability and P I is the apparent permeability, which is smaller due to the factor f p ' which represents the fr ee fr action of tracer in plasma.
Equation B5
can be solved by expanding C 2 (t -T + t') in a Taylor series about t (this should be a reasonable approximation since T is to be averaged over the capillary transit time, which is on the order of 1-2 s, and therefore times t -T + t' are within a small neighborhood of t):
1. LOGAN ET AL. + ...
(B7)
retaining terms to second order. Convergence can be tested by including (dC 2 )/(dt) and (d 2 C 2 )/(dt 2 ) in succes sive calculations and comparing results derived from the steady-state case given by Eq. B6. Substituting Eq. B7 into Eq. B5 and averaging Ce over the capillary transit time,
The first integral in Eq. B8 can be evaluated assuming a value for the capillary transit time. Using a Taylor series expansion of Ca to second order, dCa d 2 Ca T 2 Ca(t -T) = Ca(t)dt T + dt 2
2"
Substituting this expression for Ca(t -T) into Eq. B8, performing the integrations, and relating the single capil lary parameters to the average over a gram of tissue con taining N capillaries (so that PI = P dJJf = P I 1N1(A1N) = f.. S liVB and PI te = PI fLNte/(Nj) = PI1NiF = PSI/F) , Ce from Eq. B8 can be written as (for the firt-order correction set U 2 = 0 and 13 2 = 0) . Taking the derivative with respect to t (and neglecting terms higher than (�C 2 )/(dt 2 ) and (d 2 Ca)/(dt 2 », Tt[1 -PSI(UI + Ut)'I)] = PS2 F(1 -e -P SIIF ) C a -PSI F(1 -e -P SIIF ) C 2 -k3(1 -PSIUt'/2)C2 + k4(1 -PSIUt'/2)C3 dCa d 2 Ca + PSI«(j i + U2WI) dt + PSI «(j2 + U2W2) dt 2 (C6')
For Model II the three-compartment version is (note that this corresponds to Eq. C6') with U l' u 2 ' (j l' and (j 2 set to 0)
Model II (three compartments) and for Model III, Model III (three compartments)
